In today’s recent session, 3.01 million shares of the Bristol-Myers Squibb Co. (NYSE:BMY) have been traded, and its beta is 0.45. Most recently the company’s share price was $52.08, and it changed around -$0.4 or -0.76% from the last close, which brings the market valuation of the company to $105.59B. BMY at last check was trading at a discount to its 52-week high of $57.65, offering almost -10.7% off that amount. The share price’s 52-week low was $39.35, which indicates that the recent value has risen by an impressive 24.44% since then. We note from Bristol-Myers Squibb Co.’s average daily trading volume that its 10-day average is 15.0 million shares, with the 3-month average coming to 13.69 million.
Bristol-Myers Squibb Co. stock received a consensus recommendation rating of Hold, based on a mean score of 2.86. If we narrow it down even further, the data shows that 2 out of 22 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 11 recommended BMY as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Bristol-Myers Squibb Co. is expected to report earnings per share of 1.58 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bristol-Myers Squibb Co. (NYSE:BMY) trade information
Instantly BMY has been showing red trend so far today with a performance of -0.76% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 54.42 on recent trading dayincreased the stock’s daily price by 4.3%. The company’s shares are currently up 1.51% year-to-date, but still down -3.12% over the last five days. On the other hand, Bristol-Myers Squibb Co. (NYSE:BMY) is 5.69% up in the 30-day period. We can see from the shorts that 21.79 million shares have been sold at a short interest cover period of 2.28 day(s).
The consensus price target as assigned by Wall Street analysts is $66.5, which translates to bulls needing to increase their stock price by 21.68% from its current value. Analyst projections state that BMY is forecast to be at a low of $41 and a high of $85.
Bristol-Myers Squibb Co. (BMY) estimates and forecasts
Bristol-Myers Squibb Co. share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 3.57 percent over the past six months and at a -89.75% annual growth rate that is well below the industry average of 17.70%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -13.20% in revenue this quarter, and will report a decrease of -5.70% in the next quarter. The year-over-year growth rate is expected to be 11.30%, up from the previous year.
Consensus estimates provided by 17 financial analysts predict the company will bring in an average of 11.29B in revenue for the current quarter. 15 analysts expect Bristol-Myers Squibb Co. to make 11.47B in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 9.99B and 10.72B respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 13.00%. Forecasts for the next quarter put sales growth at 7.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 5.14%. Bristol-Myers Squibb Co. earnings are expected to increase by -90.33% in 2024, but the outlook is negative -4.21% per year for the next five years.
BMY Dividends
Bristol-Myers Squibb Co.’s next quarterly earnings report is expected to be released on 2024-Oct-31. The annual dividend yield of the stock is 4.61 percent and its annual dividend per share was 2.40. It is important to note, however, that the 4.61% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision. The average dividend yield for the past five years averaged 3.39 per year.
Bristol-Myers Squibb Co. (NYSE:BMY)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.11% of Bristol-Myers Squibb Co. shares, and 77.98% of them are in the hands of institutional investors. The stock currently has a share float of 78.07%. Bristol-Myers Squibb Co. stock is held by 2791.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 9.2225% of the shares, which is about 186.57 million shares worth $7.75 billion.
BLACKROCK INC., with 7.8428% or 158.66 million shares worth $6.59 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
